{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-034611","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.165178+00:00","generated_at":"2026-05-15T08:59:11.402270+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Annovis Bio CFO Mark Guerin departs; CEO Maria Maccecchini appointed acting CFO","bullets":["Mark Guerin left as CFO effective March 23, 2026; departure unrelated to any disagreement with the company.","CEO Maria Maccecchini will serve as Acting CFO until a permanent replacement is identified.","No financial impact disclosed; company continues operations with existing management."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-034611","json":"https://secwatch.observer/filing/0001104659-26-034611.json","markdown":"https://secwatch.observer/filing/0001104659-26-034611.md","text":"https://secwatch.observer/filing/0001104659-26-034611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926034611/0001104659-26-034611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926034611/tm269828d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:59:11.402270+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}